Clinical Trials Logo

Pineal Germ Cell Tumor clinical trials

View clinical trials related to Pineal Germ Cell Tumor.

Filter by:
  • None
  • Page 1

NCT ID: NCT03158064 Active, not recruiting - Germ Cell Tumor Clinical Trials

Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors

Start date: May 15, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test the safety and effectiveness of durvalumab with tremelimumab in patients with relapsed or refractory germ cell tumors.